Evidence map›Paper›PMID 26111478›Full record

ArticleInflammation2015

Phospholipid Incorporation of Non-Methylene-Interrupted Fatty Acids (NMIFA) in Murine Microglial BV-2 Cells Reduces Pro-Inflammatory Mediator Production.

Szu-Jung Chen, Lu-Te Chuang, Jia-Siang Liao, Wen-Cheng Huang, Hong-Hsin Lin

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Delta-5Lipids in health and disease · 2022
    Article
  8. Article
  9. ComparativeFrontiers in plant science · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Szu-Jung ChenDepartment of Radiation Oncology, Tao Yuan General Hospital, Tao Yuan, Taiwan.
Lu-Te ChuangDepartment of Biotechnology and Pharmaceutical Technology, Yuanpei University of Medical Technology, 306 Yuanpei Street, Hsinchu, 300, Taiwan. ltchuang@mail.ypu.edu.tw.
Jia-Siang LiaoDepartment of Biotechnology and Pharmaceutical Technology, Yuanpei University of Medical Technology, 306 Yuanpei Street, Hsinchu, 300, Taiwan.
Wen-Cheng HuangDepartment of Human Development and Family Studies, National Taiwan Normal University, Taipei, Taiwan.
Hong-Hsin LinDepartment of Biotechnology and Pharmaceutical Technology, Yuanpei University of Medical Technology, 306 Yuanpei Street, Hsinchu, 300, Taiwan.
Yuanpei University · TWNational Taiwan Normal University · TWTao Yuan General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sciadonic acid (SCA), pinolenic acid (PNA), and Δ7-eicosatrienoic acid (Δ7-ETrA) are three non-methylene-interrupted fatty acids (NMIFA). Using murine microglial BV-2 cells, this study determined how NMIFA incorporation modulated phospholipid fatty acid composition and the production of pro-inflammatory mediators. Each NMIFA was rapidly taken up and incorporated in BV-2 cells, resulting in the differential redistribution of total lipids. The cellular phospholipid fatty acid compositions were altered, and a significant decrease in the proportions of total monounsaturated fatty acids (MUFA) was observed while the proportions of NMIFA and its metabolites accounted for 38% of the fatty acid total. Incubation of microglial cells with NMIFA suppressed production of LPS-stimulated pro-inflammatory mediators, including nitric oxide (NO), prostaglandin E2 (PGE2), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), as well as the over-expression of inducible nitric oxide synthase (iNOS) and type 2 cyclooxygenase (COX-2). These inhibitory effects could be accounted for, in part, by the inactivation of mitogen-activated protein kinases (MAPK) signaling. In conclusion, Δ7-ETrA, PNA, and SCA are anti-inflammatory NMIFA that may be useful in suppressing in vitro immune responses involved in neural inflammation.

Indexed as

AnimalsAnti-Inflammatory AgentsArachidonic AcidsCell LineCyclooxygenase 2DinoprostoneDose-Response Relationship, DrugDown-RegulationEnzyme ActivationFatty Acids, MonounsaturatedInflammation MediatorsInterleukin-6Linolenic AcidsMAP Kinase Signaling SystemMiceMicroglia5,9,12-octadecatrienoic acidAnti-Inflammatory AgentsArachidonic AcidsCyclooxygenase 2Dinoprostoneeicosa-5,11,14-trienoic acideicosenoic acidFatty Acids, MonounsaturatedInflammation MediatorsInterleukin-6interleukin-6, mouseLinolenic AcidsMitogen-Activated Protein KinasesNitric OxideNitric Oxide Synthase Type IINos2 protein, mousePhospholipidsPtgs2 protein, mouseTumor Necrosis Factor-alphainflammationmicroglial cellsnon-methylene-interrupted fatty acids (NMIFA)pinolenic acid (PNA)sciadonic acid (SCA)Δ7-eicosatrienoic acid (Δ7-ETrA)

Identifiers

PMID26111478
OpenAlexW776664410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.